• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Myocarditis in COVID-19 patients: current problems.新型冠状病毒肺炎患者的心肌炎：当前的问题。
Intern Emerg Med. 2021 Aug;16(5):1123-1129. doi: 10.1007/s11739-021-02635-w. Epub 2021 Jan 23.
2
Prevalence of Clinical and Subclinical Myocarditis in Competitive Athletes With Recent SARS-CoV-2 Infection: Results From the Big Ten COVID-19 Cardiac Registry.近期感染 SARS-CoV-2 的竞技运动员中临床和亚临床心肌炎的患病率：Big Ten COVID-19 心脏登记研究结果。
JAMA Cardiol. 2021 Sep 1;6(9):1078-1087. doi: 10.1001/jamacardio.2021.2065.
3
Myocarditis and Cardiac Complications Associated With COVID-19 and mRNA Vaccination: A Pragmatic Narrative Review to Guide Clinical Practice.心肌炎与 COVID-19 及 mRNA 疫苗接种相关的心脏并发症：指导临床实践的实用叙事性综述。
Heart Lung Circ. 2022 Jul;31(7):924-933. doi: 10.1016/j.hlc.2022.03.003. Epub 2022 Apr 6.
4
Suspected myocarditis in patients with COVID-19: A multicenter case series.新型冠状病毒肺炎患者疑似心肌炎：一项多中心病例系列研究。
Medicine (Baltimore). 2021 Feb 26;100(8):e24552. doi: 10.1097/MD.0000000000024552.
5
Clinically Suspected Myocarditis in the Course of Severe Acute Respiratory Syndrome Novel Coronavirus-2 Infection: Fact or Fiction?严重急性呼吸综合征新型冠状病毒 2 感染过程中临床疑似心肌炎：事实还是虚构？
J Card Fail. 2021 Jan;27(1):92-96. doi: 10.1016/j.cardfail.2020.11.002. Epub 2020 Nov 6.
6
Mild-to-Moderate COVID-19 Infection and Myocarditis: A Review.轻度至中度新型冠状病毒肺炎感染与心肌炎：综述
Cardiol Rev. 2023;31(3):173-175. doi: 10.1097/CRD.0000000000000458. Epub 2022 May 16.
7
COVID-19 Myocarditis: An Emerging Clinical Conundrum.COVID-19 心肌炎：一个新兴的临床难题。
Curr Probl Cardiol. 2022 Sep;47(9):101268. doi: 10.1016/j.cpcardiol.2022.101268. Epub 2022 May 27.
8
Public Interest in Myocarditis during the SARS-CoV-2 Pandemic.公众对 SARS-CoV-2 大流行期间心肌炎的关注。
Disaster Med Public Health Prep. 2023 Mar 13;17:e349. doi: 10.1017/dmp.2022.307.
9
Cardiac Endotheliitis and Multisystem Inflammatory Syndrome After COVID-19.新型冠状病毒肺炎后的心脏内皮炎症和多系统炎症综合征
Ann Intern Med. 2020 Dec 15;173(12):1025-1027. doi: 10.7326/L20-0882. Epub 2020 Jul 29.
10
Myocarditis: A complication of COVID-19 and long-COVID-19 syndrome as a serious threat in modern cardiology.心肌炎：作为现代心脏病学中的严重威胁，是新型冠状病毒肺炎（COVID-19）及其后遗症的一种并发症 。
Cardiol J. 2022;29(1):178-179. doi: 10.5603/CJ.a2021.0155. Epub 2021 Nov 23.

引用本文的文献

1
Myocardial Fibrosis in a Recovered COVID-19 Patient: A Case Indicating Prior Myocarditis.一名康复的新冠病毒肺炎患者的心肌纤维化：一例提示既往心肌炎的病例
Cureus. 2025 May 11;17(5):e83927. doi: 10.7759/cureus.83927. eCollection 2025 May.
2
Genetic and Epigenetic Intersections in COVID-19-Associated Cardiovascular Disease: Emerging Insights and Future Directions.新冠病毒相关心血管疾病中的遗传与表观遗传交叉点：新见解与未来方向
Biomedicines. 2025 Feb 16;13(2):485. doi: 10.3390/biomedicines13020485.
3
Impact of underlying diseases and complications on COVID-19 mortality in South Korea: analysis of national health insurance service data.基础疾病及并发症对韩国新冠疫情死亡率的影响：基于国民健康保险服务数据的分析
Arch Public Health. 2025 Jan 23;83(1):20. doi: 10.1186/s13690-025-01509-3.
4
Nanomedicines for cardiovascular disease.心血管疾病的纳米药物
Nat Cardiovasc Res. 2023 Apr;2(4):351-367. doi: 10.1038/s44161-023-00232-y. Epub 2023 Apr 3.
5
Complete recovery after fulminant myocarditis in a patient with COVID-19.一名新冠肺炎患者暴发性心肌炎后完全康复。
Pak J Med Sci. 2024 Mar-Apr;40(4):785-789. doi: 10.12669/pjms.40.4.8685.
6
Fatal Myocarditis following COVID-19 mRNA Immunization: A Case Report and Differential Diagnosis Review.新冠病毒mRNA疫苗接种后发生的致命性心肌炎：一例报告及鉴别诊断综述
Vaccines (Basel). 2024 Feb 13;12(2):194. doi: 10.3390/vaccines12020194.
7
Determinants of COVID-19 vaccine-induced myocarditis.新冠病毒疫苗诱导的心肌炎的决定因素。
Ther Adv Drug Saf. 2024 Jan 27;15:20420986241226566. doi: 10.1177/20420986241226566. eCollection 2024.
8
Myopericarditis as a Delayed Complication of COVID-19 Infection: A Case Report.新冠病毒感染的延迟并发症——心肌心包炎：一例报告
Cureus. 2023 Oct 7;15(10):e46655. doi: 10.7759/cureus.46655. eCollection 2023 Oct.
9
Mesenchymal Stem Cells in the Treatment of COVID-19.间充质干细胞在治疗 COVID-19 中的作用。
Int J Mol Sci. 2023 Sep 30;24(19):14800. doi: 10.3390/ijms241914800.
10
Acute Cardiac Manifestations of SARS-CoV-2 Infection: Spotting the Clot.新型冠状病毒2型感染的急性心脏表现：发现血栓形成
Case Rep Cardiol. 2023 Sep 14;2023:6366959. doi: 10.1155/2023/6366959. eCollection 2023.

本文引用的文献

1
Repurposed Antiviral Drugs for Covid-19 - Interim WHO Solidarity Trial Results.用于治疗新冠肺炎的抗病毒药物 repurposed - 世界卫生组织团结试验中期结果
N Engl J Med. 2021 Feb 11;384(6):497-511. doi: 10.1056/NEJMoa2023184. Epub 2020 Dec 2.
2
Clinically Suspected Myocarditis in the Course of Severe Acute Respiratory Syndrome Novel Coronavirus-2 Infection: Fact or Fiction?严重急性呼吸综合征新型冠状病毒 2 感染过程中临床疑似心肌炎：事实还是虚构？
J Card Fail. 2021 Jan;27(1):92-96. doi: 10.1016/j.cardfail.2020.11.002. Epub 2020 Nov 6.
3
COVID-19 myocarditis and prospective heart failure burden.COVID-19 心肌炎与潜在心力衰竭负担。
Expert Rev Cardiovasc Ther. 2021 Jan;19(1):5-14. doi: 10.1080/14779072.2021.1844005. Epub 2020 Nov 27.
4
Lopinavir-ritonavir in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.洛匹那韦利托那韦在因 COVID-19 住院的患者中的应用（RECOVERY）：一项随机、对照、开放标签、平台试验。
Lancet. 2020 Oct 24;396(10259):1345-1352. doi: 10.1016/S0140-6736(20)32013-4. Epub 2020 Oct 5.
5
Pathological features of COVID-19-associated myocardial injury: a multicentre cardiovascular pathology study.COVID-19 相关心肌损伤的病理特征：一项多中心心血管病理学研究。
Eur Heart J. 2020 Oct 14;41(39):3827-3835. doi: 10.1093/eurheartj/ehaa664.
6
[Non-ischemic ventricular dysfunction in COVID-19 patients: characteristics and implications for cardiac imaging on the basis of current evidence].[新型冠状病毒肺炎患者的非缺血性心室功能障碍：基于现有证据的特征及对心脏成像的意义]
G Ital Cardiol (Rome). 2020 Oct;21(10):739-749. doi: 10.1714/3431.34196.
7
Coronavirus-induced myocarditis: A meta-summary of cases.冠状病毒性心肌炎：病例汇总分析。
Heart Lung. 2020 Nov-Dec;49(6):681-685. doi: 10.1016/j.hrtlng.2020.08.013. Epub 2020 Aug 20.
8
Systematic Review of COVID-19 Related Myocarditis: Insights on Management and Outcome.COVID-19 相关心肌炎的系统评价：管理和预后的见解。
Cardiovasc Revasc Med. 2021 Feb;23:107-113. doi: 10.1016/j.carrev.2020.08.028. Epub 2020 Aug 18.
9
Cardiac Involvement in COVID-19-Assessment with Echocardiography and Cardiac Magnetic Resonance Imaging.新冠病毒病中的心脏受累——超声心动图和心脏磁共振成像评估
SN Compr Clin Med. 2020;2(7):845-851. doi: 10.1007/s42399-020-00344-7. Epub 2020 Jun 10.
10
Endothelial dysfunction in COVID-19: a position paper of the ESC Working Group for Atherosclerosis and Vascular Biology, and the ESC Council of Basic Cardiovascular Science.新型冠状病毒肺炎中的血管内皮功能障碍：欧洲心脏病学会动脉粥样硬化和血管生物学工作组以及欧洲心脏病学会心血管基础科学理事会立场文件。
Cardiovasc Res. 2020 Dec 1;116(14):2177-2184. doi: 10.1093/cvr/cvaa230.

新型冠状病毒肺炎患者的心肌炎：当前的问题。

Myocarditis in COVID-19 patients: current problems.

机构信息

Cardiology Center, University of Ferrara, Viale Aldo Moro 8, 44024, Cona, Ferrara, Italy.

Maria Cecilia Hospital, GVM Care & Research, Cotignola, Ravenna, Italy.

出版信息

Intern Emerg Med. 2021 Aug;16(5):1123-1129. doi: 10.1007/s11739-021-02635-w. Epub 2021 Jan 23.

DOI:10.1007/s11739-021-02635-w
PMID:33484452
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7823176/
Abstract

Myocarditis has been reported as a possible clinical presentation or complication in patients with coronavirus disease (COVID)-19 due to SARS-CoV-2. Despite the alarm that this possibility generated among physicians, there is paucity of information about mechanisms, prevalence, prognosis, diagnosis and therapy of myocarditis in the context of COVID-19. This brief review has the goal to revise and summarize current knowledge on myocarditis in COVID-19 patients and underline problems especially related to diagnosis and treatment.

摘要

心肌炎已被报道为 SARS-CoV-2 引起的冠状病毒病 (COVID-19) 患者的一种可能的临床表现或并发症。尽管这种可能性引起了医生们的警惕，但关于 COVID-19 背景下心肌炎的发病机制、患病率、预后、诊断和治疗方面的信息却很少。这篇简短的综述旨在复习和总结 COVID-19 患者心肌炎的现有知识，并特别强调与诊断和治疗相关的问题。